BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23758962)

  • 1. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
    Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
    Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
    Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
    Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
    Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
    Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
    Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
    Aka JA; Calvo EL; Lin SX
    Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
    Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
    PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation.
    Perotti C; Liu R; Parusel CT; Böcher N; Schultz J; Bork P; Pfitzner E; Groner B; Shemanko CS
    Breast Cancer Res; 2008; 10(6):R94. PubMed ID: 19014541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.
    Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA
    Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
    Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S
    Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
    Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
    PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
    Sakamoto K; Triplett AA; Schuler LA; Wagner KU
    Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
    Fang F; Rycyzyn MA; Clevenger CV
    Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
    Linher-Melville K; Singh G
    BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2017 Apr; 8(16):27353-27363. PubMed ID: 28423697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.